Suchergebnisse - "Brufsky, Adam"

PubPharm (30)

1

Predicting clinical benefit from continuation of cyclin dependent kinase (CDK) 4/6 inhibitors beyond progression

enthalten in: Annals of translational medicine | 2023

von Foldi, J. | Brufsky, A.

CommentOn: Clin Cancer Res. 2023 Jan 4;29(1):67-80. - PMID 36165912

2

Phase I Study of Entinostat and Nivolumab with or without Ipilimumab in Advanced Solid Tumors (ETCTN-9844)

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Roussos Torres, E. | Rafie, C. | Wang, C. | +18

CommentOn: Clin Cancer Res. 2021 Nov 1;27(21):5731. - PMID 34725123

3

The mechanism behind flaring/triggering of autoimmunity disorders associated with COVID-19

enthalten in: Autoimmunity reviews | 2021

von Redwan, E. | Alghamdi, M. | El-Aziz, T. | +26

CommentOn: Lancet Rheumatol. 2021 Jan;3(1):e6-e8. - PMID 33521668

4

A plain language summary of the ASCENT study : Sacituzumab Govitecan for metastatic triple-negative breast cancer

enthalten in: Future oncology (London, England) | 2021

von Bardia, A. | Hurvitz, S. | Rugo, H. | +7

CommentOn: N Engl J Med. 2021 Apr 22;384(16):1529-1541. - PMID 33882206

5

Ovarian function suppression as a potential mechanism of chemotherapy

enthalten in: EBioMedicine | 2021

von Gomez Marti, J. | Nasrazadani, A. | Brufsky, A.

CommentOn: EBioMedicine. 2021 Jul;69:103451. - PMID 34161883

6

Potential interventions for SARS-CoV-2 infections : Zinc showing promise

enthalten in: Journal of medical virology | 2021

von Brewer, J. | Gomez Marti, J. | Brufsky, A.

CommentOn: J Med Virol. 2020 May;92(5):479-490. - PMID 32052466

7

Reply to T. J. A. Dekker, D.-C. Mo et al, and A. Seidman et al

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Saura, C. | Oliveira, M. | Kim, S. | +3

CommentOn: J Clin Oncol. 2020 Sep 20;38(27):3138-3149. - PMID 32678716

8

Magee Equations™ and response to neoadjuvant chemotherapy in ER+/HER2-negative breast cancer : a multi-institutional study

enthalten in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc | 2021

von Bhargava, R. | Esposito, N. | OʹConnor, S. | +11

CommentOn: Mod Pathol. 2017 Aug;30(8):1078-1085. - PMID 28548119

9

Bisphosphonate Choice as Adjuvant Therapy for Breast Cancer : Does it Matter?

enthalten in: Journal of the National Cancer Institute | 2020

von Brufsky, A. | Mathew, A.

CommentOn: J Natl Cancer Inst. 2020 Jul 1;112(7):698-707. - PMID 31693129

10

Capivasertib inhibits a key pathway in metastatic breast cancer

enthalten in: The Lancet. Oncology | 2020

von Nasrazadani, A. | Brufsky, A.

CommentOn: Lancet Oncol. 2020 Mar;21(3):345-357. - PMID 32035020